Swapnil Hiremath  MDJan 11, 2023

Tonight and tomorrow on #NephJC we discuss the NEFIGARD trial of #Nefecon (a targeted release #budesonide) in #IgANephropathy - supposedly with no systemic steroid exposure - but read the summary and decide for yourself http://www.nephjc.com/news/nefigard-trial

#nephrology #glomerulonephritis

#VisualAbstract from @Priti899

Nefecon in IgA Nephropathy, the Nefigard trial — NephJC

This week, we will discuss NEFIGARD, the trial of a targeted release steroid. It reduces proteinuria in IgA nephropathy - should it upstage humble prednisone?

NephJC